• Organized by the Cross Company Abuse Liability Consortium (CCALC)

  • Facilitated with the aid of the College on Problems of Drug Dependence (CPDD)

  • With presentations by the FDA representatives 

Abuse Deterrent Formulation Science Meeting 

Discussion of the FDA Draft Guidance for Industry: Abuse Deterrent Opioids – Evaluation and Labeling


We gratefully acknowledge sponsorship from the following companies:

  • AbbVie
  • CRI LifeTree
  • Eli Lilly and Company 
  • INC Research
  • Inspirion Delivery Technologies, LLC
  • Janssen Scientific Affairs, LLC
  • Grünenthal USA
  • GW Pharmaceuticals & Otsuka Pharmaceutical Development and Commercialization
  • Purdue Pharma L.P.  
  • Vince & Associates Clinical Research

We gratefully acknowledge support of the following organizations:

  • The College on Problems of Drug Dependence
  • Safety Pharmacology Society